T. Rowe Price Global Value Equity Fund TRGVX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 24.20  /  +1.07 %
  • Total Assets 310.2M
  • Adj. Expense Ratio
    0.890%
  • Expense Ratio 0.890%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Global Large-Stock Value
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.66%
  • Turnover 77%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 9:00 PM GMT+0

Morningstar’s Analysis TRGVX

Will TRGVX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A compelling value-oriented global equity strategy.

Senior Analyst Kongkon Gogoi

Kongkon Gogoi

Senior Analyst

Summary

T. Rowe Price Global Value Equity continues to earn our conviction as a compelling option for investors seeking value-oriented global equities exposure. The substantially experienced and stable investment team led by Sebastian Mallet has continued to execute a differentiated and effective investment process efficiently, upholding our confidence in the strategy to deliver long-term outperformance. The strategy’s opportunistic value approach spans the value spectrum and leverages rigorous bottom-up research and effective execution. These attributes provide a robust foundation for the strategy’s ability to deliver risk-adjusted outperformance over the long term, supporting an Above Average rating for the People and Process pillars.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TRGVX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 23.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

5.74 18M
Technology

Alphabet Inc Class C

3.64 11M
Communication Services

JPMorgan Chase & Co

2.15 7M
Financial Services

ExxonMobil Holdings Corp

2.11 7M
Energy

Wheaton Precious Metals Corp

1.74 5M
Basic Materials

Gilead Sciences Inc

1.70 5M
Healthcare

Franco-Nevada Corp

1.67 5M
Basic Materials

Cencora Inc

1.61 5M
Healthcare

AstraZeneca PLC

1.57 5M
Healthcare

Micron Technology Inc

1.56 5M
Technology

Sponsor Center